EUVIMEDEUVIMED entdecken
Open Access

GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion

Hui Zhang, Anny Mulya, Stephan Nieuwoudt, Bolormaa Vandanmagsar, Ruth McDowell, Elizabeth C Heintz, Elizabeth R M Zunica, J Jason Collier iD, Nadejda Bozadjieva-Kramer, Randy J Seeley, Christopher L Axelrod, John P Kirwan iD

Diabetes · 01.08.2023 · 72 (8) · 1070-1082

DOI: 10.2337/db22-0019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 24.05.2023. Verfasst von Hui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exercise is a first-line treatment for type 2 diabetes and preserves β-cell function by hitherto unknown mechanisms. We postulated that proteins from contracting skeletal muscle may act as cellular signals to regulate pancreatic β-cell function. We used electric pulse stimulation (EPS) to induce contraction in C2C12 myotubes and found that treatment of β-cells with EPS-conditioned medium enhanced glucose-stimulated insulin secretion (GSIS). Transcriptomics and subsequent targeted validation revealed growth differentiation factor 15 (GDF15) as a central component of the skeletal muscle secretome. Exposure to recombinant GDF15 enhanced GSIS in cells, islets, and mice. GDF15 enhanced GSIS by upregulating the insulin secretion pathway in β-cells, which was abrogated in the presence of a GDF15 neutralizing antibody. The effect of GDF15 on GSIS was also observed in islets from GFRAL-deficient mice. Circulating GDF15 was incrementally elevated in patients with pre- and type 2 diabetes and positively associated with C-peptide in humans with overweight or obesity. Six weeks of high-intensity exercise training increased circulating GDF15 concentrations, which positively correlated with improvements in β-cell function in patients with type 2 diabetes. Taken together, GDF15 can function as a contraction-induced protein that enhances GSIS through activating the canonical signaling pathway in a GFRAL-independent manner. Article Highlights Exercise improves glucose-stimulated insulin secretion through direct interorgan communication. Contracting skeletal muscle releases growth differentiation factor 15 (GDF15), which is required to synergistically enhance glucose-stimulated insulin secretion. GDF15 enhances glucose-stimulated insulin secretion by activating the canonical insulin release pathway. Increased levels of circulating GDF15 after exercise training are related to improvements in β-cell function in patients with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Secreting CellsHumansMiceAnimalsInsulin SecretionGlucoseGrowth Differentiation Factor 15InsulinMuscle ContractionMuscle, Skeletal

Substanzen

GlucoseGrowth Differentiation Factor 15InsulinGDF15 protein, human

Autor:innen und Institutionen

  • Department of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH.
  • Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA.
  • Islet Biology and Inflammation Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA.
  • Department of Surgery, University of Michigan, Ann Arbor, MI.
  • Veterans Affairs Ann Arbor Healthcare System, Research Service, Ann Arbor, MI.

ORCID-Profile: J Jason Collier, John P Kirwan

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIAMS NIH HHS
  • BLRD VA
  • NIA NIH HHS
  • NIGMS NIH HHS
  • NCRR NIH HHS
  • NCCIH NIH HHS

Zitieren

APA

Zhang, H., Mulya, A., Nieuwoudt, S., Vandanmagsar, B., McDowell, R., Heintz, E. C., Zunica, E. R. M., Collier, J. J., Bozadjieva-Kramer, N., Seeley, R. J., Axelrod, C. L., & Kirwan, J. P. (2023). GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion. Diabetes, 72(8), 1070-1082. https://doi.org/10.2337/db22-0019

Vancouver

Zhang H, Mulya A, Nieuwoudt S, Vandanmagsar B, McDowell R, Heintz EC, et al. GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion. Diabetes. 2023;72(8):1070-1082. doi:10.2337/db22-0019

BibTeX
@article{Zhang2023,
  author = {Zhang, Hui and Mulya, Anny and Nieuwoudt, Stephan and Vandanmagsar, Bolormaa and McDowell, Ruth and Heintz, Elizabeth C and Zunica, Elizabeth R M and Collier, J Jason and Bozadjieva-Kramer, Nadejda and Seeley, Randy J and Axelrod, Christopher L and Kirwan, John P},
  title = {GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion},
  journal = {Diabetes},
  year = {2023},
  volume = {72},
  number = {8},
  pages = {1070--1082},
  doi = {10.2337/db22-0019}
}
Kostenlos starten →